GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), ...
GlobalData on MSN6d
GSK CEO addresses declining trust in vaccines following Trump re-electionGSK CEO Emma Walmsley said the sector would need to wait to see who is appointed in key roles in the Trump administration to ...
amid funding threats London, 11 November 2024 – ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced it is pledging ...
A new generic version of varenicline – originally sold in the UK as Champix by Pfizer – has now been approved for use by the ...
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today ...
Consumers Rank Nearly 200 Taylor Swift Tracks, Revealing the Commercial Truth Behind Her Last 10 Albums and the True Value of ...
The FTSE 100 index slumped 99.42 points, 1.2%, at 8,025.77. The FTSE 250 closed down 295.73 points, 1.4%, at 20,427.80. The AIM All-Share fell 7.07 points, 1.0%, at 730.86.
pence - 'buy' Jefferies cuts GSK to 'hold' (buy) - price target 1,525 (2,000) pence Jefferies raises Ashtead price target to 6,800 (6,150) pence - 'buy' RBC raises National Grid price target to 1,150 ...
On Tuesday night, millions of Americans watched as former president Donald J. Trump gathered up enough electoral votes needed ...
The US group's division has reported a pre-tax profit of $39.5m (£30.6m) for the 12 months to 31 January, 2024, according to ...
This week saw two major life sciences investments in London, as GSK unveiled plans to move its headquarters to a central location in the city, while an ambitious plan to develop a new biosciences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback